News
13h
TipRanks on MSNElicio announces publication of ELI-002 updated AMPLIFY-201 Phase 1 data
Elicio Therapeutics (ELTX) announced the publication of follow-up data from the Phase 1 AMPLIFY-201 study evaluating ELI-002 in the peer-reviewed ...
1d
GMA Network on MSNPhase 1 of EDSA Busway rehab begins Monday, Aug. 11, 2025
Phase 1 of the EDSA Busway rehabilitation began on Monday, August 11, 2025, focusing on improvements to four of its stations. These stations are Monumento, Bagong Barrio, North Avenue, and Guadalupe.
The first patient in Cohort 3, the fifth patient in the trial, has completed the first week of cycle 1 following the ...
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...
The Phase 1 clinical trials program increases patients’ access to novel research by bringing it closer to their homes. Distance should never stand between you and the latest medical breakthroughs. As ...
We report the results of the phase 1 study of cemiplimab for expansion cohorts of patients with locally advanced or metastatic cutaneous squamous-cell carcinoma, as well as the results of the ...
The Telangana Council of Higher Education (TGCHE) has announced the Telangana State Education Common Entrance Test (TS/TG ...
Phase 2 of the voting closes at noon ET on July 2, with starting lineups for each league announced on July 6 at 5 PM ET on ESPN. For now, let's dig into the Phase 1 voting results.
U.S. President Donald Trump has directed federal agencies to assess China's performance under the Phase 1 trade deal that he signed with Beijing in 2020 during his first term at the White House.
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.
Based on the preliminary Phase 1 safety results, a safety review committee comprising study staff and independent physicians concluded the compound was well tolerated by participants. Martin Low, CEO ...
Previous reviews of phase 1 oncology trials reported a rate of response to treatment of 4 to 6 percent and a toxicity-related death rate of 0.5 percent. These results may not reflect the rates in c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results